Tenders/ONEX01-PALBOCICLIB - IBRANCE

ONEX01-PALBOCICLIB - IBRANCE

Consorci Corporació Sanitària Parc Taulí de Sabadell

Published: Oct 20, 2026

Updated: Oct 21, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from Spain and sourced through the TED (Tenders Electronic Daily) platform, concerns the procurement of pharmaceutical products. The title 'ONEX01-PALBOCICLIB - IBRANCE' clearly indicates the specific medication being sought: Palbociclib, marketed under the brand name Ibrance. This is a drug used in the treatment of certain types of breast cancer. The contracting authority, likely a healthcare provider or public health institution, is seeking to acquire this medication. Typical requirements for such a tender include adherence to strict pharmaceutical quality standards, specified packaging, and delivery timelines. Bidders, typically pharmaceutical manufacturers or authorized distributors, must demonstrate their ability to supply the drug in the required quantities, ensuring its authenticity, safety, and efficacy. Compliance with regulatory requirements for the storage, handling, and distribution of pharmaceuticals is paramount. The tender documents will outline the specific quantities, dosage forms, packaging requirements, and delivery schedules. Evaluation will likely focus on the compliance with specifications, quality assurance, reliability of supply, and potentially pricing.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 20, 2026. Last refreshed today. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Consorci Corporació Sanitària Parc Taulí de Sabadell

Consorci Corporació Sanitària Parc Taulí de Sabadell has issued 90 procurement notices on BidsFactory, including 13 currently open and 60 awarded contracts. Activity concentrates in Health & Medical, Finance & Banking, and Information & Communication Technology. All notices are published for Spain. Notices are distributed via PLACSP - Plataforma de Contratación del Sector Público and TED - Tenders Electronic Daily (EU). Most recent publication: October 20, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Consorci Corporació Sanitària Parc Taulí de Sabadell in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.